Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zetagen Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Zetagen Therapeutics

Zetagen Therapeutics

ZetaGen Therapeutics develops innovative bone growth products using a unique molecular pathway.

HQ
Syracuse, NY, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Zetagen Therapeutics is dedicated to developing innovative bone growth products using a unique molecular pathway. The company focuses on commercializing a small molecule-based osteoinductive platform technology to treat bone-related injuries and conditions. Their market focus includes therapies for metastatic and primary cancers, with a particular emphasis on bone metastases and cervical degenerative disc disease.

Zetagen Therapeutics has achieved significant milestones, including the approval to begin a pilot study of their ZetaFuse® Bone Graft in Australia. The company has also appointed notable experts like Debasish (Debu) Tripathy, M.D., to its advisory board. Their local therapy for treating bone metastases in breast cancer patients has shown promising results, such as decreased pain and fracture prevention, underscoring their impact in the field of bone health and cancer treatment.

Zetagen Therapeutics - Similar Companies

DiscGenics logo

DiscGenics

discgenics.com

Bone Biologics logo

Bone Biologics

Genascence logo

Genascence

genascence.com

CelgenTek logo

CelgenTek

Nostopharma logo

Nostopharma

nostopharma.com

ZetaRx Biosciences logo

ZetaRx Biosciences

ZY Therapeutics logo

ZY Therapeutics

zytinc.com

Zenopharm logo

Zenopharm

TumorGen logo

TumorGen

tumorgen.net

Progenerative Medical logo

Progenerative Medical

progenerative.com

Bone-Rad Therapeutics logo

Bone-Rad Therapeutics

bone-rad.com

Spinogenix logo

Spinogenix

spinogenix.com

OssiFi logo

OssiFi

ossifi.com

MedGene Therapeutics logo

MedGene Therapeutics

medgenetx.com

SynerGene Therapeutics logo

SynerGene Therapeutics

Zetagen Therapeutics - Quick Facts

Who are Zetagen Therapeutics' competitors?

Companies similar to Zetagen Therapeutics include DiscGenics, Bone Biologics, Genascence and CelgenTek.

When was Zetagen Therapeutics founded?

Zetagen Therapeutics was founded in 2015.

Where is Zetagen Therapeutics' headquarters located?

Zetagen Therapeutics' headquarters is located in Syracuse, NY, US.

When was Zetagen Therapeutics' last funding round?

Zetagen Therapeutics' most recent funding round was for $9.8M (USD) in August 2023.

How much has Zetagen Therapeutics raised to-date?

As of Aug 11, 2023, Zetagen Therapeutics has raised a total of $14.4M (USD).

How many employees does Zetagen Therapeutics have?

Zetagen Therapeutics has 5 employees as of Feb 5, 2024.

Zetagen Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bone Growth Products
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified